tiprankstipranks
Sabra Healthcare Reit (MX:SBRA)
NASDAQ:SBRA
Mexico Market
SBRA
Sabra Healthcare REIT
RESEARCH TOOLSreports

Sabra Healthcare REIT (SBRA) Stock Forecast & Price Target

― Followers
See the Price Targets and Ratings of:

SBRA Analyst Ratings

Moderate Buy
13Ratings
Moderate Buy
5 Buy
7 Hold
1 Sell
Based on 13 analysts giving stock ratings to
Sabra
Healthcare REIT
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

SBRA Stock 12 Month Forecast

Average Price Target

$394.26
Based on 13 Wall Street analysts offering 12 month price targets for Sabra Healthcare REIT in the last 3 months. The average price target is $394.26 with a high forecast of $472.74 and a low forecast of $327.94. The average price target represents a ― change from the last price of ―.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"317":"$317","356":"$356","395":"$395","434":"$434","473":"$473"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":472.73873319,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$472.74</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":394.25871614446925,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$394.26</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":327.9406100981,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$327.94</span>\n  </div></div>","useHTML":true}}],"tickPositions":[317,356,395,434,473],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,348,357.59528716846154,367.1905743369231,376.7858615053846,386.38114867384616,395.9764358423077,405.57172301076923,415.1670101792308,424.7622973476923,434.35758451615385,443.9528716846154,453.5481588530769,463.14344602153847,{"y":472.73873319,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,348,351.55836278034377,355.1167255606876,358.67508834103137,362.23345112137514,365.7918139017189,369.35017668206274,372.9085394624065,376.4669022427503,380.0252650230941,383.5836278034379,387.14199058378165,390.7003533641255,{"y":394.25871614446925,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,348,346.45697000754615,344.9139400150923,343.37091002263844,341.82788003018464,340.2848500377308,338.74182004527694,337.1987900528231,335.65576006036923,334.1127300679154,332.5697000754616,331.02667008300773,329.4836400905539,{"y":327.9406100981,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":330.659,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":318.88,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":324.226,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":332.808,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":332.808,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":320.97,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":320.97,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":320.97,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":326.049,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":326.049,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":326.049,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":348,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":348,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$472.74Average Price Target$394.26Lowest Price Target$327.94
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Truist Financial Analyst forecast on MX:SBRA
Michael Lewis
Truist Financial
Truist Financial
$385.19→$420.21
Buy
―
Reiterated
07/22/26
Analysts Conflicted on These Real Estate Names: Healthcare Realty Trust (NYSE: HR), Forestar Group (NYSE: FOR) and Sabra Healthcare REIT (NASDAQ: SBRA)
Deutsche Bank Analyst forecast on MX:SBRA
Omotayo Okusanya
Deutsche Bank
Deutsche Bank
$385.19→$437.72
Buy
―
Reiterated
07/22/26
Sabra Health Care price target raised to $25 from $22 at Deutsche BankSabra Health Care price target raised to $25 from $22 at Deutsche Bank
Robert W. Baird Analyst forecast on MX:SBRA
Wes Golladay
Robert W. Baird
Robert W. Baird
$385.19→$402.7
Hold
―
Reiterated
07/22/26
Sabra Health Care price target raised to $23 from $22 at BairdSabra Health Care price target raised to $23 from $22 at Baird
Bank of America Securities Analyst forecast on MX:SBRA
Farrell Granath
Bank of America Securities
Bank of America Securities
$437.72
Buy
―
Reiterated
07/22/26
Sabra: Portfolio Repositioning and SHOP-Driven Earnings Visibility Support Buy Rating; 12-Month Price Target Reiterated at $25
Citizens JMP Analyst forecast on MX:SBRA
Aaron Hecht
Citizens JMP
Citizens JMP
$402.7→$437.72
Buy
―
Reiterated
07/22/26
Sabra Health Care price target raised to $25 from $23 at CitizensSabra Health Care price target raised to $25 from $23 at Citizens
Barclays Analyst forecast on MX:SBRA
Richard Hightower
Barclays
Barclays
$367.69
Hold
―
Reiterated
07/22/26
Barclays Sticks to Their Hold Rating for Sabra Healthcare REIT (SBRA)
Wells Fargo Analyst forecast on MX:SBRA
Unknown Analyst
Wells Fargo
Not Ranked
Wells Fargo
$315.16→$472.74
Buy
―
Assigned
07/15/26
Sabra Healthcare REIT (SBRA) Receives a Buy from Wells Fargo
UBS Analyst forecast on MX:SBRA
Michael Goldsmith
UBS
UBS
$385.19→$367.69
Hold
―
Assigned
07/08/26
Sabra Health Care price target lowered to $21 from $22 at UBSSabra Health Care price target lowered to $21 from $22 at UBS
Citi Analyst forecast on MX:SBRA
Seth Bergey
Citi
Not Ranked
Citi
$420.21→$332.67
Hold
―
Downgraded
06/23/26
Sabra Health Care downgraded to Neutral from Buy at CitiSabra Health Care downgraded to Neutral from Buy at Citi
Scotiabank Analyst forecast on MX:SBRA
Nicholas Yulico
Scotiabank
Scotiabank
$385.19→$332.67
Hold
―
Reiterated
06/18/26
Sabra Health Care price target lowered to $19 from $22 at ScotiabankSabra Health Care price target lowered to $19 from $22 at Scotiabank
Raymond James Analyst forecast on MX:SBRA
Dave Rodgers
Raymond James
Raymond James
$327.94
Sell
―
Initiated
06/16/26
Sabra Health Care resumed with an Underperform at Raymond JamesSabra Health Care resumed with an Underperform at Raymond James
Cantor Fitzgerald Analyst forecast on MX:SBRA
Richard Anderson
Cantor Fitzgerald
Cantor Fitzgerald
$367.69→$385.19
Hold
―
Reiterated
05/11/26
Sabra Health Care price target raised to $22 from $21 at Cantor FitzgeraldSabra Health Care price target raised to $22 from $21 at Cantor Fitzgerald
BMO Capital Analyst forecast on MX:SBRA
Juan C. Sanabria
BMO Capital
BMO Capital
$385.19→$402.7
Hold
―
Reiterated
04/29/26
Analyst Maintains Hold on Sabra, Lifts Price Target to $23 Amid Solid SHOP Performance but Ongoing Credit and Refinancing Risks
Jefferies Analyst forecast on MX:SBRA
Unknown Analyst
Jefferies
Not Ranked
Jefferies
$385.19
Buy
―
Reiterated
12/15/25
Jefferies Keeps Their Buy Rating on Sabra Healthcare REIT (SBRA)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Truist Financial Analyst forecast on MX:SBRA
Michael Lewis
Truist Financial
Truist Financial
$385.19→$420.21
Buy
―
Reiterated
07/22/26
Analysts Conflicted on These Real Estate Names: Healthcare Realty Trust (NYSE: HR), Forestar Group (NYSE: FOR) and Sabra Healthcare REIT (NASDAQ: SBRA)
Deutsche Bank Analyst forecast on MX:SBRA
Omotayo Okusanya
Deutsche Bank
Deutsche Bank
$385.19→$437.72
Buy
―
Reiterated
07/22/26
Sabra Health Care price target raised to $25 from $22 at Deutsche BankSabra Health Care price target raised to $25 from $22 at Deutsche Bank
Robert W. Baird Analyst forecast on MX:SBRA
Wes Golladay
Robert W. Baird
Robert W. Baird
$385.19→$402.7
Hold
―
Reiterated
07/22/26
Sabra Health Care price target raised to $23 from $22 at BairdSabra Health Care price target raised to $23 from $22 at Baird
Bank of America Securities Analyst forecast on MX:SBRA
Farrell Granath
Bank of America Securities
Bank of America Securities
$437.72
Buy
―
Reiterated
07/22/26
Sabra: Portfolio Repositioning and SHOP-Driven Earnings Visibility Support Buy Rating; 12-Month Price Target Reiterated at $25
Citizens JMP Analyst forecast on MX:SBRA
Aaron Hecht
Citizens JMP
Citizens JMP
$402.7→$437.72
Buy
―
Reiterated
07/22/26
Sabra Health Care price target raised to $25 from $23 at CitizensSabra Health Care price target raised to $25 from $23 at Citizens
Barclays Analyst forecast on MX:SBRA
Richard Hightower
Barclays
Barclays
$367.69
Hold
―
Reiterated
07/22/26
Barclays Sticks to Their Hold Rating for Sabra Healthcare REIT (SBRA)
Wells Fargo Analyst forecast on MX:SBRA
Unknown Analyst
Wells Fargo
Not Ranked
Wells Fargo
$315.16→$472.74
Buy
―
Assigned
07/15/26
Sabra Healthcare REIT (SBRA) Receives a Buy from Wells Fargo
UBS Analyst forecast on MX:SBRA
Michael Goldsmith
UBS
UBS
$385.19→$367.69
Hold
―
Assigned
07/08/26
Sabra Health Care price target lowered to $21 from $22 at UBSSabra Health Care price target lowered to $21 from $22 at UBS
Citi Analyst forecast on MX:SBRA
Seth Bergey
Citi
Not Ranked
Citi
$420.21→$332.67
Hold
―
Downgraded
06/23/26
Sabra Health Care downgraded to Neutral from Buy at CitiSabra Health Care downgraded to Neutral from Buy at Citi
Scotiabank Analyst forecast on MX:SBRA
Nicholas Yulico
Scotiabank
Scotiabank
$385.19→$332.67
Hold
―
Reiterated
06/18/26
Sabra Health Care price target lowered to $19 from $22 at ScotiabankSabra Health Care price target lowered to $19 from $22 at Scotiabank
Raymond James Analyst forecast on MX:SBRA
Dave Rodgers
Raymond James
Raymond James
$327.94
Sell
―
Initiated
06/16/26
Sabra Health Care resumed with an Underperform at Raymond JamesSabra Health Care resumed with an Underperform at Raymond James
Cantor Fitzgerald Analyst forecast on MX:SBRA
Richard Anderson
Cantor Fitzgerald
Cantor Fitzgerald
$367.69→$385.19
Hold
―
Reiterated
05/11/26
Sabra Health Care price target raised to $22 from $21 at Cantor FitzgeraldSabra Health Care price target raised to $22 from $21 at Cantor Fitzgerald
BMO Capital Analyst forecast on MX:SBRA
Juan C. Sanabria
BMO Capital
BMO Capital
$385.19→$402.7
Hold
―
Reiterated
04/29/26
Analyst Maintains Hold on Sabra, Lifts Price Target to $23 Amid Solid SHOP Performance but Ongoing Credit and Refinancing Risks
Jefferies Analyst forecast on MX:SBRA
Unknown Analyst
Jefferies
Not Ranked
Jefferies
$385.19
Buy
―
Reiterated
12/15/25
Jefferies Keeps Their Buy Rating on Sabra Healthcare REIT (SBRA)
Stocks with the Highest Top Analyst Consensus in the Real Estate Sector
IRMIron Mountain
BEKEKE Holdings Inc. Sponsored ADR Class A
AHRAmerican Healthcare REIT, Inc.
RITMRithm Capital
NMRKNewmark Group
Find stocks in the Real Estate sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Sabra Healthcare REIT

3 Months
Michael LewisTruist Financial
Success Rate
11/16 ratings generated profit
69%
Average Return
+5.07%
Copying Michael Lewis's trades and holding each position for 3 Months would result in 68.75% of your transactions generating a profit, with an average return of +5.07% per trade.
1 Year
Aaron HechtCitizens JMP
Success Rate
7/10 ratings generated profit
70%
Average Return
+7.02%
Copying Aaron Hecht's trades and holding each position for 1 Year would result in 70.00% of your transactions generating a profit, with an average return of +7.02% per trade.
2 Years
Michael LewisTruist Financial
Success Rate
13/16 ratings generated profit
81%
Average Return
+24.46%
Copying Michael Lewis's trades and holding each position for 2 Years would result in 81.25% of your transactions generating a profit, with an average return of +24.46% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SBRA Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
0
0
0
0
0
Buy
3
3
2
2
8
Hold
9
10
8
8
9
Sell
0
0
0
1
1
Strong Sell
0
0
0
0
0
total
12
13
10
11
18
In the current month, SBRA has received 8 Buy Ratings, 9 Hold Ratings, and 1 Sell Ratings. SBRA average Analyst price target in the past 3 months is 394.26.
Each month's total comprises the sum of three months' worth of ratings.

SBRA Financial Forecast

SBRA Earnings Forecast

Next quarter’s earnings estimate for SBRA is $2.99 with a range of $2.80 to $3.33. The previous quarter’s EPS was $2.80. SBRA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 49.64% of the time in the same period. In the last calendar year SBRA has Performed in-line its overall industry.
Next quarter’s earnings estimate for SBRA is $2.99 with a range of $2.80 to $3.33. The previous quarter’s EPS was $2.80. SBRA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 49.64% of the time in the same period. In the last calendar year SBRA has Performed in-line its overall industry.

SBRA Sales Forecast

Next quarter’s sales forecast for SBRA is $3.84B with a range of $3.75B to $3.99B. The previous quarter’s sales results were $3.90B. SBRA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 72.47% of the time in the same period. In the last calendar year SBRA has Performed in-line its overall industry.
Next quarter’s sales forecast for SBRA is $3.84B with a range of $3.75B to $3.99B. The previous quarter’s sales results were $3.90B. SBRA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 72.47% of the time in the same period. In the last calendar year SBRA has Performed in-line its overall industry.

SBRA Stock Forecast FAQ

What is MX:SBRA’s average 12-month price target, according to analysts?
Based on analyst ratings, Sabra Healthcare Reit’s 12-month average price target is 394.26.
    What is MX:SBRA’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for MX:SBRA, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Sabra Healthcare Reit a Buy, Sell or Hold?
        Sabra Healthcare Reit has a consensus rating of Moderate Buy, which is based on 5 buy ratings, 7 hold ratings and 1 sell ratings.
          What is Sabra Healthcare Reit’s share price target?
          The average share price target for Sabra Healthcare Reit is 394.26. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is $472.74 ,and the lowest forecast is $327.94. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Sabra Healthcare Reit?
            Sabra Healthcare Reit’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 13 Wall Streets Analysts.
              How can I buy shares of Sabra Healthcare Reit?
              To buy shares of MX:SBRA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.